Astra Wealth Partners
ABBV icon

Astra Wealth Partners’s AbbVie ABBV Stock Holding History

Astra Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$260K Buy
996
+64
+7% +$16.4K 0.15% 80
2026
Q2 		$234K Buy
+932
New +$201K 0.12% 94
2026
Q1 		– Sell
-897
Closed -$205K – 96
2025
Q4 		$205K Buy
+897
New +$204K 0.12% 96

Other funds holding ABBV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return

Astra Wealth Partners's ABBV Position: Q3 2026 in Review

Astra Wealth Partners increased its AbbVie (ABBV) stake by 6.9% in Q3 2026, buying an estimated $16.4K and bringing the position to 996 shares worth $260K. The position accounts for 0.15% of the portfolio, ranked #80.

Astra Wealth Partners first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 3,064 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Astra Wealth Partners held 996 shares of AbbVie worth $260K as of Q3 2026.
  • Astra Wealth Partners bought 64 AbbVie shares in Q3 2026, an estimated $16.4K.
  • AbbVie made up 0.15% of Astra Wealth Partners's portfolio in Q3 2026, its #80 holding.
  • Astra Wealth Partners first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • 3,064 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Astra Wealth Partners's 13F filing for Q3 2026, filed 6 Nov 2026.